Maintain ACN at current exposure with $150 hard floor stop; five-way convergence to Hold
Hold correctly threads the 12x forward P/E valuation floor defense with technical caution (200-SMA still 12.7% overhead at $204), captures dividend carry without committing fresh capital, and forces a calendar-based decision at Q4 FY26 earnings catalyst. Prior decision pattern (Aug 12 Buy was worst at -0.9% raw / -1.6% alpha) demonstrates aggressive calls consistently underperform Hold on this setup.
| Position | Action |
|---|---|
| Current position | Maintain current exposure; do not initiate new longs or scale in aggressively |
| Reference level for new exposure | ~$152 (50-SMA) — avoid aggressive analyst's $165/$155 layered buy-stops inside consolidation range |
| If upgrade trigger fires (close above $204 on volume ≥8M shares) | First target $185-193 (below Bollinger upper band at ~$192.87), then $204 (200-SMA), then $240-250 May-June 2025 consolidation |
| Aggressive analyst's $150 stop with 75% sizing | Mathematically inconsistent — 15-20% drawdown on 75% position equals 11-15% portfolio hit |
Accenture is a $73B cash machine mispriced at 12x earnings with 17% EPS growth, 24.4% ROE, and 8% capital return yield, where the 44% rally from June 2026 lows signals an early-stage sentiment reversal as AI deal flow proves the technology is a growth catalyst rather than existential threat.
| Indicator | Value | Signal |
|---|---|---|
| Price | $176.89 | neutral |
| 10-EMA | $173.91 | bullish |
| 50-SMA | $152.20 | bearish |
| 200-SMA | $204.20 | bearish |
| RSI (14) | 65.86 | bullish |
| MACD Line | +8.65 | bullish |
| MACD Signal | +7.34 | bullish |
| MACD Histogram | +1.30 | bullish |
| Bollinger Upper Band | $192.87 | neutral |
| Bollinger Mid Band | $163.99 | neutral |
| Bollinger Lower Band | $135.12 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close below $150 on volume
Then: Downgrade to Underweight
Revenue continues compounding with mid-single-digit growth despite bear narrative of structural decline
↩ rebuts: “Bears claim FY26 revenue growth is soft and company is entering structural decline”
EV: +$20+ toward $204 (first target $185-$193) · concedes: Risk is real that price rolls over and retests $152 (descending 50-SMA); If bookings don't inflect by September/October Q4 print, value-trap narrative reasserts; Price still 15% below 200-SMA ($204.20) — trend-following discipline says broken trend; Bookings remain soft and are single largest overhang; Goodwill at 37% of assets creates impairment risk if cash flows ever break
ACN's 44% bounce is a bear-market rally trap, not a new bull market — the technical setup (declining 200-SMA, failed $180 resistance, falling volume), deteriorating fundamentals (margin compression, soft bookings, cautious AI guidance), and smart money exits indicate the path of least resistance is lower, not higher.
· concedes: ACN is not going to zero — the franchise has real value, real cash flow, and real assets; The dividend is real at 3.65%; The balance sheet is 'okay' — not a catastrophic debt situation; A confirmed close above $204 on volume would constitute a valid regime change signal worth reassessing
→ vs conservative: Conservative analyst anchored on wrong reference points (200-SMA as ceiling vs actual resistance at $220-$230) and misframed risk-reward as 1:1 when true asymmetry is 2:1
→ vs conservative: Treatment of Polen/Aoris exits as bearish signal is backwards—forced selling overhang has cleared and stock rallied 44% despite it
→ vs conservative: Conservative analyst is pricing in permanence to what fundamentals show is temporary sentiment dislocation; 58% correction on a 24% ROE business with $12B FCF is cyclical, not structural
→ vs neutral: Waiting for Q4 FY26 earnings in late September is 'the most expensive sentence in the entire analysis'—either stock breaks out and we're chasing at $200+, or it pulls back and we get better entry anyway
→ vs neutral: Conditional probability favors action now: every day of waiting surrenders the 8% capital return yield without accumulating the position
| neutral |
| ATR (14) | $7.84 | neutral |
| VWMA (20) | $170.44 | bullish |
| Volume | 6.1M shares | neutral |
| 50-SMA vs 200-SMA Spread | -$52 (bearish death cross) | bearish |
Support: 170 · 164 · 152 | Resistance: 185 · 193 · 204
ACN is in a recovery rally (~$177) after bottoming at $122.96 in late June 2026, representing a ~44% bounce from lows but still down ~58% from mid-2025 highs near $295. Short-term indicators are bullish (RSI 65.86, MACD +8.65, price above 10-EMA and VWMA), but medium- and long-term trends remain firmly bearish (price below 50-SMA $152.20 and 200-SMA $204.20). Volatility is elevated but normalizing (ATR $7.84 vs $9.15 peak). Key resistance sits at $185–$193 (Bollinger upper band/mid-July highs), with support at $170 and $164. The overall recommendation is HOLD pending either a confirmed breakout above $185–$193 or a pullback to $163–$170 for improved risk-reward entries.
Market Capitalization
$108.25B
PE Ratio (TTM)
14.14
Forward PE
12.06
PEG Ratio
1.31
Price to Book
3.39
EPS (TTM)
$12.51
Forward EPS
$14.66
Dividend Yield
3.65%
Beta
1.07
52-Week High
$291.09
52-Week Low
$118.15
50-Day Average
$153.02
200-Day Average
$207.89
Revenue (TTM)
$73.10B
Gross Profit (TTM)
$23.40B
EBITDA (TTM)
$12.94B
Net Income (TTM)
$7.79B
Gross Margin
~32.0%
Operating Margin
16.96%
Net Profit Margin
10.66%
Return on Equity (ROE)
24.41%
Return on Assets (ROA)
10.90%
Total Assets
$68.81B
Cash & Equivalents
$10.17B
Total Debt
$8.39B
Net Debt
–$1.78B (Net Cash)
Long-Term Debt
$5.03B
Total Stockholders' Equity
$31.89B
Goodwill
$25.32B
Total Liabilities
$35.30B
Current Ratio
1.34
Working Capital
$7.33B
Operating Cash Flow (Q3 FY26)
$3.79B
Capital Expenditure
$0.19B
Free Cash Flow (Q3 FY26)
$3.60B
Free Cash Flow (TTM)
$12.09B
Dividends Paid
$0.995B
Share Buybacks
$1.18B
Capital Return Yield
~8%
Goodwill / Assets
37%
Strengths
Concerns
Accenture presents a quality-at-a-discount setup with strong fundamentals intact: 24.41% ROE, $12.09B TTM FCF, and ~8% capital return yield, trading at a forward PE of just 12.06x. However, the stock near its 52-week low with ~35% discount to the 200-day moving average reflects significant negative momentum likely tied to macro concerns about IT spending and margin pressure. The $25.32B goodwill (37% of assets) represents a meaningful concentration risk. The recommendation is HOLD — existing positions are supported by fundamentals, but new entrants should scale in rather than take full positions given the lack of price stabilization confirmation.